Hip and knee replacement specialist Corin has named Stefano Alfonsi as its new Chief Executive Officer and acting Chairman.
The appointment follows the group's takeover by investment vehicle 2IL Orthopaedics in a 70p per share cash offer valuing the company at around £30.5m.
Corin confirmed that Peter Huntley, Linda Wilding and David Young have all resigned.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Marco Fumagalli, Enrico Amo and Pierluca Antolini, all of whom are directors at 2IL Orthopaedics, have been appointed to the board of Corin as non-executive directors.
Stefano Alfonsi, who will start work at Corin following a short transitional period, is currently employed by the medical devices company Inion.
Alfonsi has also held senior positions at Johnson and Johnson, DePuy and Covidien and most recently as Chief Executive Officer of Lima.
CJ
-
House prices rise 2.9% – will the recovery continue?House prices grew by 2.9% on an annual basis in September. Will Budget policies and ‘higher-for-longer’ rates dent the recovery?
-
Nvidia earnings: what to expectNvidia announces earnings after market close on 20 November. What should investors expect from the semiconductor giant?
